Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
1
7%
Ph phase_3
2
14%
Ph phase_1
4
29%
Ph phase_4
1
7%
Ph phase_2
6
43%

Phase Distribution

4

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
4(28.6%)
Phase 2Efficacy & side effects
6(42.9%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
1(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(6)
Terminated(3)
Other(5)

Detailed Status

Completed6
unknown5
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (28.6%)
Phase 26 (42.9%)
Phase 32 (14.3%)
Phase 41 (7.1%)
N/A1 (7.1%)

Trials by Status

completed643%
terminated17%
unknown536%
withdrawn214%

Recent Activity

0 active trials
Showing 5 of 14
completedphase_2

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

NCT00004860
unknownphase_2

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

NCT03121313
unknownnot_applicable

Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

NCT02836977
completedphase_2

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

NCT02447679
unknownphase_4

A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer

NCT02887365
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT00004860Phase 2

Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer

Completed
NCT03121313Phase 2

Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+

Unknown
NCT02836977Not Applicable

Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

Unknown
NCT02447679Phase 2

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Completed
NCT02887365Phase 4

A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer

Unknown
NCT00660894Phase 3

Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

Completed
NCT00009815Phase 1

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Withdrawn
NCT00002801Phase 1

Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer

Completed
NCT00009828Phase 1

Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors

Withdrawn
NCT00336947Phase 3

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Unknown
NCT00003925Phase 1

Combination Chemotherapy In Treating Patients With Advanced Cancer

Completed
NCT00005608Phase 2

Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer

Terminated
NCT00519688Phase 2

UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma

Completed
NCT00855881Phase 2

Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14